Evidence map›Paper›PMID 33425681›Full record

ArticleIDCases2021

BCGitis as the primary manifestation of chronic granulomatous disease.

Nastaran Khalili, Iraj Mohammadzadeh, Neda Khalili, Raúl Jimenez Heredia, Samaneh Zoghi, Kaan Boztug, Nima Rezaei

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nastaran KhaliliCancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Iraj MohammadzadehNoncommunicable Pediatric Diseases Research Center, Amirkola Hospital, Babol University of Medical Sciences, Babol, Iran.
Neda KhaliliCancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Raúl Jimenez HerediaLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Samaneh ZoghiLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Kaan BoztugLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Nima RezaeiResearch Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Universal Scientific Education and Research Network · IRAustrian Academy of Sciences · ATBabol University of Medical Sciences · IRLudwig Boltzmann Institute for Rare and Undiagnosed Diseases · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with primary immunodeficiency disease (PID) are not only vulnerable to mycobacterial disease, but are also more likely to develop adverse events following BCG vaccination. These events can range from regional disease (BCGitis) to disseminated disease (BCGosis). Chronic granulomatous disease (CGD), which is characterized by impaired leukocyte phagocytic function, is one of the many inherited PIDs that increase the body's susceptibility to recurrent bacterial and fungal infections. Here, we report a 6-year-old boy with no significant past medical history who presented with progressive lymphadenopathy six years after BCG vaccination. He was later diagnosed with CGD on further evaluation.

Indexed as

BCGiosisBCGitisBCG vaccinationChronic granulomatous diseaseLymphadenopathyPrimary immunodeficiency disease

Identifiers

PMID33425681
PMCPMC7785948
OpenAlexW3114003942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.